Xeme Biopharma

Chemicals & Related Products · Illinois, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1120 N Du Page Ave, Lombard, Illinois, 6...

Phone Number

(844) 709-9363

Website

www.xemebiopharma.com

Revenue

<$5 Million

Industry

Chemicals & Related Products Manufacturing Business Services Research & Development

About Xeme Biopharma

XEME Biopharma Inc. is a clinical-stage company dedicated to developing innovative therapeutic cancer vaccines, focusing on active cancer immunotherapy. The company operates under FDA guidance and aims to advance cancer treatment beyond traditional methods such as surgery and chemotherapy. XEME utilizes two integrated technology platforms, Aggregon and Oncolipin, to manufacture personalized cancer vaccines, specifically targeting leukemia and lymphoma. Their lead products include Oncoquest-CLL and Oncoquest-L, designed for personalized treatment approaches.Explore more
SIC Code 28,283NAICS Code 32,325Show more

Xeme Biopharma Org Chart

MP
United States flag for contact location.
Mircea Popescu

President & Chief Executive Officer

PhoneEmail
RR
United States flag for contact location.
Richard Robb

Founder & Vice President, Research, Developme...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Xeme Biopharma

Compare insights from companies similar to Xeme Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Xeme Biopharma

<$5M
11-50
Private
-
2005
MP
Mircea PopescuPresident & CEO
Immunomic Therapeutics
$5.3M
11-50
Private
$83.5M
2005
DK
Dong-Gun KimCEO
Immunova Therapeutics
<$5M
1-10
Private
-
2012
N/A
Veana Therapeutics
<$5M
1-10
Private
-
2012
LH
Lauren HartmannManager, Clinical Trial & Consultant
Intensity Therapeutics
<$5M
1-10
Public
$25.4M
2012
JW
John WesolowskiPrincipal Accounting Officer & Controller
OncoSynergy
<$5M
1-10
Private
$6.7M
2011
W. Carbonell, Chief Scientific Officer at OncoSynergy
W. CarbonellChief Scientific Officer
Illustration of an envelope

Xeme Biopharma Tech Stack

A closer look at the technologies used by Xeme Biopharma

Sentry

By

Sentry
F5 BIG-IP Platform

By

F5
F5 BIG-IP Application Security Mana...

By

F5
Wix

By

Wix
See more technologies

Top Chemicals & Related Products Companies

Top companies in Canada by revenue

Cancarb
AKNEL Group
Premier Tech
Doktor Doom
Ferus
View Full List

Top companies in Australia by revenue

Dy-mark
Crop Care Australasia
RLF Asia
ITW AAMTech
Zagro Australia
View Full List

Top companies in New Zealand by revenue

Cohe Group
Pioneer Hi-Bred International New Zealand
TF Group
Resene Paints
CrossChem
View Full List
See more top companies

Frequently Asked Questions Regarding Xeme Biopharma

What is Xeme Biopharma's official website?
Xeme Biopharma's official website is www.xemebiopharma.com What is Xeme Biopharma's Revenue?
Xeme Biopharma's revenue is <$5 Million What is Xeme Biopharma's SIC code?
Xeme Biopharma's SIC: 28,283 What is Xeme Biopharma's NAICS code?
Xeme Biopharma's NAICS: 32,325 How many employees does Xeme Biopharma have?
Xeme Biopharma has 11-50 employees What industry does Xeme Biopharma belong to?
Xeme Biopharma is in the industry of: Chemicals & Related Products, Manufacturing, Business Services What is Xeme Biopharma competition?
Xeme Biopharma top competitors include: Intensity Therapeutics, Veana Therapeutics, Immunomic Therapeutics, Immunova Therapeutics What technology does Xeme Biopharma use?
Some of the popular technologies that Xeme Biopharma uses are: Sentry, F5 BIG-IP Platform, F5 BIG-IP Application Security Manager, Wix How do I contact Xeme Biopharma?
Xeme Biopharma contact info: Phone number: (844) 709-9363 Website: www.xemebiopharma.com What does Xeme Biopharma do?

XEME Biopharma Inc. is a clinical-stage company dedicated to developing innovative therapeutic cancer vaccines, focusing on active cancer immunotherapy. The company operates under FDA guidance and aims to advance cancer treatment beyond traditional methods such as surgery and chemotherapy. XEME utilizes two integrated technology platforms, Aggregon... and Oncolipin, to manufacture personalized cancer vaccines, specifically targeting leukemia and lymphoma. Their lead products include Oncoquest-CLL and Oncoquest-L, designed for personalized treatment approaches.Read More

 Is Xeme Biopharma a public company?
Xeme Biopharma is private company therefore does not currently have an official ticker symbol
See more information about Xeme Biopharma

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search